Paxlovid Hype About Long COVID

Get Your Patriot911 Newsletter In Your Email Inbox

The unusual intense coverage of a new study showing benefits of the Pfizer antiviral drug Paxlovid can best be explained by the collusion between the media and the big drug industry. In its 2022 financial guidance, the company reported Paxlovid revenue of $22 billion. True, the new data are impressive in some ways. But some… Read More »

Read the full story ›

Share to break through the censorship!

Check out our sponsor Patriot Switch

JOIN US @Patriot911News on our Telegram, Twitter, Facebook Page and Groups, and other social media for instant news updates!

Patriot911News depends on your support as a patriot-ran conservative breaking news headlines website. Donate now

Author

Newswire: Newswire articles and reports are produced by another news agency, and the Patriot911News editors believe you'll find it of interest. All content is attributed, belongs to its respective owners, and is used with permission.